Xianjun Yu
Impact in
- Cancer Research top 0.1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Oncology top 0.1%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 261
- Pancreatic and Hepatic Oncology Research 190
- Lung Cancer Research Studies 28
- Cancer Cells and Metastasis 26
-
- Epigenetics and DNA Methylation 32
- RNA modifications and cancer 26
- Co-authors
- Jin Xu (169 shared papers)Si Shi (124 shared papers)Chen Liang (71 shared papers)Jie Hua (69 shared papers)Qingcai Meng (62 shared papers)Quanxing Ni (114 shared papers)Chen Liu (105 shared papers)Guopei Luo (80 shared papers)
- Journals
- Cancer Letters (21 papers)Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (17 papers)Pancreatology (15 papers)Acta Biochimica et Biophysica Sinica (13 papers)Annals of Surgical Oncology (11 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xianjun Yu
535 papers receiving 22.6k citations
Xianjun Yu's Hit Papers
Peers
Comparison fields: 5 of 182
- Cancer Research 5.3k
- Oncology 7.7k
- Immunology 3.6k
- Molecular Biology 8.8k
- Pulmonary and Respiratory Medicine 3.0k
Countries citing papers authored by Xianjun Yu
This map shows the geographic impact of Xianjun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianjun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianjun Yu more than expected).
Fields of papers citing papers by Xianjun Yu
This network shows the impact of papers produced by Xianjun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianjun Yu. The network helps show where Xianjun Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xianjun Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 552 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives Hit paper breakdown → | 2021 | 1538 |
| 2 | Ferroptosis, necroptosis, and pyroptosis in anticancer immunity Hit paper breakdown → | 2020 | 969 |
| 3 | The role of necroptosis in cancer biology and therapy Hit paper breakdown → | 2019 | 813 |
| 4 | Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research Hit paper breakdown → | 2022 | 618 |
| 5 | The role of collagen in cancer: from bench to bedside Hit paper breakdown → | 2019 | 573 |
| 6 | Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype Hit paper breakdown → | 2017 | 440 |
| 7 | 2008 | 422 | |
| 8 | Applications of single-cell sequencing in cancer research: progress and perspectives Hit paper breakdown → | 2021 | 380 |
| 9 | 2010 | 283 | |
| 10 | Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter Hit paper breakdown → | 2020 | 271 |
| 11 | 2012 | 265 | |
| 12 | 2020 | 243 | |
| 13 | Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets Hit paper breakdown → | 2023 | 229 |
| 14 | 2018 | 225 | |
| 15 | 2019 | 217 | |
| 16 | 2011 | 209 | |
| 17 | 2020 | 206 | |
| 18 | 2020 | 204 | |
| 19 | 2012 | 171 | |
| 20 | Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives Hit paper breakdown → | 2022 | 170 |
About Xianjun Yu
Xianjun Yu is a scholar working on Oncology, Molecular Biology, Epidemiology, Cancer Research and Immunology, having authored 552 papers that have together received 22.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (190 papers), Neuroendocrine Tumor Research Advances (84 papers), Epigenetics and DNA Methylation (32 papers), Lung Cancer Research Studies (28 papers), Cancer, Hypoxia, and Metabolism (27 papers), Cancer Cells and Metastasis (26 papers), RNA modifications and cancer (26 papers) and Cancer Genomics and Diagnostics (24 papers). The work is most often cited by research in Cancer Research (5.3k citations), Oncology (7.7k citations), Immunology (3.6k citations), Molecular Biology (8.8k citations) and Pulmonary and Respiratory Medicine (3.0k citations). Xianjun Yu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jin Xu, Si Shi, Chen Liang, Jie Hua, Qingcai Meng, Quanxing Ni, Chen Liu, Guopei Luo, Jiang Liu and Jiang Long. Their work appears in journals such as Cancer Letters, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Pancreatology, Acta Biochimica et Biophysica Sinica and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.